These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense. Westra ER; van Houte S; Oyesiku-Blakemore S; Makin B; Broniewski JM; Best A; Bondy-Denomy J; Davidson A; Boots M; Buckling A Curr Biol; 2015 Apr; 25(8):1043-9. PubMed ID: 25772450 [TBL] [Abstract][Full Text] [Related]
3. Deciphering and shaping bacterial diversity through CRISPR. Briner AE; Barrangou R Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713 [TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740 [TBL] [Abstract][Full Text] [Related]
5. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition. Bradde S; Mora T; Walczak AM Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281 [TBL] [Abstract][Full Text] [Related]
6. Host diversity limits the evolution of parasite local adaptation. Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566 [TBL] [Abstract][Full Text] [Related]
7. Five big mysteries about CRISPR's origins. Ledford H Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279 [No Abstract] [Full Text] [Related]
8. CRISPR/Cas9 Immune System as a Tool for Genome Engineering. Hryhorowicz M; Lipiński D; Zeyland J; Słomski R Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445 [TBL] [Abstract][Full Text] [Related]
9. How adaptive immunity constrains the composition and fate of large bacterial populations. Bonsma-Fisher M; Soutière D; Goyal S Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7462-E7468. PubMed ID: 30038015 [TBL] [Abstract][Full Text] [Related]
10. [CRISPR/Cas systems in genome engineering of bacteriophages]. Liang CJ; Meng FM; Ai YC Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946 [TBL] [Abstract][Full Text] [Related]
11. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes]. Bernheim A Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652 [TBL] [Abstract][Full Text] [Related]
12. Avoidance of Self during CRISPR Immunization. Weissman JL; Stoltzfus A; Westra ER; Johnson PLF Trends Microbiol; 2020 Jul; 28(7):543-553. PubMed ID: 32544441 [TBL] [Abstract][Full Text] [Related]
13. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections. Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970 [TBL] [Abstract][Full Text] [Related]
14. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages. Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522 [TBL] [Abstract][Full Text] [Related]
15. Immigration of susceptible hosts triggers the evolution of alternative parasite defence strategies. Chabas H; van Houte S; Høyland-Kroghsbo NM; Buckling A; Westra ER Proc Biol Sci; 2016 Aug; 283(1837):. PubMed ID: 27581884 [TBL] [Abstract][Full Text] [Related]
16. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems. Giovannangeli C; Concordet JP Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487 [No Abstract] [Full Text] [Related]
17. How bacteria control the CRISPR-Cas arsenal. Leon LM; Mendoza SD; Bondy-Denomy J Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146 [TBL] [Abstract][Full Text] [Related]